Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Peters

Showing results (881-890 of 1,006) with videos related to

Pageof 101
Sort By:
Translational Psychiatry|July 10, 2020
In vivo human brain expression of histone deacetylases in bipolar disorderChieh-En J Tseng, Tonya M Gilbert, Mary C Catanese, et al.
International Forum of Allergy & Rhinology|January 6, 2026
Early and Sustained Improvements in Sense of Smell With Tezepelumab Treatment in Patients With Chronic Rhinosinusitis With Nasal Polyps (WAYPOINT)Joaquim Mullol, Joseph K Han, Tanya M Laidlaw, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 29, 2022
Responder analysis to demonstrate the effect of targeting type 2 inflammatory mechanisms with dupilumab across objective and patient-reported endpoints for patients with severe chronic rhinosinusitis with nasal polyps in the SINUS-24 and SINUS-52 studiesClaus Bachert, Anju T Peters, Enrico Heffler, et al.
The Journal of Clinical Investigation|June 26, 2018
The COPII cargo adapter SEC24C is essential for neuronal homeostasisBo Wang, Joung Hyuck Joo, Rebecca Mount, et al.
The Journal of Allergy and Clinical Immunology|February 18, 2010
Evidence for altered activity of the IL-6 pathway in chronic rhinosinusitis with nasal polypsAnju T Peters, Atsushi Kato, Ning Zhang, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 1, 2022
Improvement in patient-reported "taste" and association with smell in dupilumab-treated patients with severe chronic rhinosinusitis with nasal polyps from the SINUS-24 and SINUS-52 trialsAnju T Peters, Zachary M Soler, Robert C Kern, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 26, 2019
Associations Between Inflammatory Endotypes and Clinical Presentations in Chronic RhinosinusitisWhitney W Stevens, Anju T Peters, Bruce K Tan, et al.
The Journal of Allergy and Clinical Immunology|October 15, 2014
Increased noneosinophilic nasal polyps in chronic rhinosinusitis in US second-generation Asians suggest genetic regulation of eosinophiliaMahboobeh Mahdavinia, Lydia A Suh, Roderick G Carter, et al.
International Forum of Allergy & Rhinology|August 26, 2024
EDS-FLU efficacy in patients with chronic rhinosinusitis with or without prior sinus surgery in ReOpen1 and ReOpen2 randomized controlled trialsSarah K Wise, Nithin D Adappa, Rakesh K Chandra, et al.
International Forum of Allergy & Rhinology|April 17, 2026
Reply to: S. N. Katkuri et al. and H. Liu et al. on Early and Sustained Improvements in Sense of Smell With Tezepelumab Treatment in Patients With Chronic Rhinosinusitis With Nasal Polyps (WAYPOINT)Joaquim Mullol, Joseph K Han, Tanya M Laidlaw, et al.
Pageof 101

Showing results (881-890 of 1,006) with videos related to

Sort By:
Pageof 101
Translational Psychiatry|July 10, 2020
In vivo human brain expression of histone deacetylases in bipolar disorderChieh-En J Tseng, Tonya M Gilbert, Mary C Catanese, et al.
International Forum of Allergy & Rhinology|January 6, 2026
Early and Sustained Improvements in Sense of Smell With Tezepelumab Treatment in Patients With Chronic Rhinosinusitis With Nasal Polyps (WAYPOINT)Joaquim Mullol, Joseph K Han, Tanya M Laidlaw, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 29, 2022
Responder analysis to demonstrate the effect of targeting type 2 inflammatory mechanisms with dupilumab across objective and patient-reported endpoints for patients with severe chronic rhinosinusitis with nasal polyps in the SINUS-24 and SINUS-52 studiesClaus Bachert, Anju T Peters, Enrico Heffler, et al.
The Journal of Clinical Investigation|June 26, 2018
The COPII cargo adapter SEC24C is essential for neuronal homeostasisBo Wang, Joung Hyuck Joo, Rebecca Mount, et al.
The Journal of Allergy and Clinical Immunology|February 18, 2010
Evidence for altered activity of the IL-6 pathway in chronic rhinosinusitis with nasal polypsAnju T Peters, Atsushi Kato, Ning Zhang, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 1, 2022
Improvement in patient-reported "taste" and association with smell in dupilumab-treated patients with severe chronic rhinosinusitis with nasal polyps from the SINUS-24 and SINUS-52 trialsAnju T Peters, Zachary M Soler, Robert C Kern, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 26, 2019
Associations Between Inflammatory Endotypes and Clinical Presentations in Chronic RhinosinusitisWhitney W Stevens, Anju T Peters, Bruce K Tan, et al.
The Journal of Allergy and Clinical Immunology|October 15, 2014
Increased noneosinophilic nasal polyps in chronic rhinosinusitis in US second-generation Asians suggest genetic regulation of eosinophiliaMahboobeh Mahdavinia, Lydia A Suh, Roderick G Carter, et al.
International Forum of Allergy & Rhinology|August 26, 2024
EDS-FLU efficacy in patients with chronic rhinosinusitis with or without prior sinus surgery in ReOpen1 and ReOpen2 randomized controlled trialsSarah K Wise, Nithin D Adappa, Rakesh K Chandra, et al.
International Forum of Allergy & Rhinology|April 17, 2026
Reply to: S. N. Katkuri et al. and H. Liu et al. on Early and Sustained Improvements in Sense of Smell With Tezepelumab Treatment in Patients With Chronic Rhinosinusitis With Nasal Polyps (WAYPOINT)Joaquim Mullol, Joseph K Han, Tanya M Laidlaw, et al.
Pageof 101